Octagon Capital Advisors’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-83,500
Closed -$8.62M 36
2022
Q3
$8.62M Buy
+83,500
New +$8.62M 1.49% 17